Home>Topics>Stocks>Vertex Pharmaceuticals

Vertex Pharmaceuticals VRTX

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

      Headlines

      Mon, 21 Jul 2014

      By DoctoRx : Background : When the Fed noted some froth in "smaller" biotechs last week, large ones also got slammed. Biogen Idec (NASDAQ: BIIB ) fell more than 7% after that statement. Gilead Sciences (NASDAQ: GILD ) fell 5% peak-to-trough. Small ones got dumped big-time. Is it but a passing ...

    2. Vertex CSO retires

      Headlines

      Thu, 10 Jul 2014

      Vertex Pharmaceuticals ( VRTX ) EVP of Global R&D and Chief Scientific Officer Peter Mueller, Ph.D., announces his retirement effective October 31, 2014, following a planned transition period. Post your comment!

    3. Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14)

      Headlines

      Thu, 10 Jul 2014

      By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday July 9. The Four Horsemen of Biotech: Celgene (NASDAQ: CELG ), Regeneron (NASDAQ: REGN ), Biogen Idec (NASDAQ: BIIB ), Gilead (NASDAQ: GILD ) Cramer consulted the technical ...

    4. Vertex applies for a label expansion for Kalydeco

      Headlines

      Mon, 30 Jun 2014

      Vertex Pharmaceuticals ( VRTX +1% ) files an sNDA with the FDA for the approval of Kalydeco (ivacaftor) as a treatment for cystic fibrosis (CF) in patients

    5. CHMP recommends label expansion for Kalydeco

      Headlines

      Fri, 27 Jun 2014

      Medicinal Products for Human Use (CHMP) recommends that the European Medicines Agency (EMA) approve Vertex Pharmaceuticals ' ( VRTX ) Kalydeco ( ivacaftor ) for cystic fibrosis (CF) patients ages six and older who have one of eight non-G551D

    6. Vertex Soars On Phase III Trial Results: Assessing The Upside Potential From Here

      Headlines

      Wed, 25 Jun 2014

      By DoctoRx: Background : Vertex Pharmaceuticals ( VRTX ) is one of a group of biotech/biopharma companies that focuses on oral medications, not injectable proteins. The company has

    7. Positive Results For Vertex Pharmaceuticals ; Ok Results For Structured Note Holders

      Headlines

      Wed, 25 Jun 2014

      This morning Vertex Pharmaceutical ( VRTX ) announced positive results for phase ..... with roughly $20 Million in notional on VRTX . As I wrote in my blog post on binary ..... with two unattractive outcomes - if the VRTX clinical trial was successful, the stock

    8. Midday Gainers / Losers

      Headlines

      Tue, 24 Jun 2014

      Top 10 Gainers: VRTX +40% . CRMD +33% . XGTI +32% . KONE +32% . NURO +25% . ISR +18% . MEET +17% . UBIC +16% . INWK +12% . SR +12

    9. New Morningstar Analyst Report for Vertex Pharmaceuticals Inc

      Stock Reports

      Tue, 24 Jun 2014

      willing to sell material amounts of stock rather than maintain their shareholdings as long-term investors. Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. The firm's lead drug

    10. UPDATE 2-Vertex cystic fibrosis combo succeeds in key late-stage trials

      Headlines

      Tue, 24 Jun 2014

      June 24 (Reuters) - A combination of Vertex Pharmaceuticals Inc's cystic fibrosis drugs succeeded in improving lung function in a pair of closely watched late-stage trials, likely offering

    « Prev12345Next »
    Content Partners